We hypothesized that this analysis would enhance the knowledge about Nectin-2 and Nectin-4 regarding their potential function as novel biomarkers associated with tumor aggressiveness and metastatic potential in LSCC, contributing to risk stratification and therapeutic decision-making. This evidence concerns the gene NECTIN2 and neoplasm.